Zydus Lifesciences acquires Agenus Biologics facilities in US, enters global CDMO market EP News Bureau Jun 4, 2025 Company also signs licensing deal for exclusive rights to immuno-oncology therapies Botensilimab and Balstilimab in India and Sri…
